ES2079485T3 - Composiciones farmaceuticas y un dispositivo para administrar las mismas. - Google Patents

Composiciones farmaceuticas y un dispositivo para administrar las mismas.

Info

Publication number
ES2079485T3
ES2079485T3 ES90913280T ES90913280T ES2079485T3 ES 2079485 T3 ES2079485 T3 ES 2079485T3 ES 90913280 T ES90913280 T ES 90913280T ES 90913280 T ES90913280 T ES 90913280T ES 2079485 T3 ES2079485 T3 ES 2079485T3
Authority
ES
Spain
Prior art keywords
pct
tablet
lozenge
sec
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90913280T
Other languages
English (en)
Inventor
William H Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioglan Ireland R&D Ltd
Original Assignee
Bioglan Ireland R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898919446A external-priority patent/GB8919446D0/en
Priority claimed from GB898919447A external-priority patent/GB8919447D0/en
Application filed by Bioglan Ireland R&D Ltd filed Critical Bioglan Ireland R&D Ltd
Application granted granted Critical
Publication of ES2079485T3 publication Critical patent/ES2079485T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0092—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine for holding medicines in, or fixing medicines on, a tooth, e.g. holder containing medicines fixed on a tooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

SE DESCRIBE UNA TABLETA FARMACEUTICA O PASTILLA QUE CONTIENE UN AGENTE FARMACEUTICAMENTE ACTIVO NO ABSORBIBLE, EN COMBINACION CON UNA MATRIZ DE TABLETA, COLOCADA PARA PROPORCIONAR UNA LIBERACION CONTROLADA Y CONTINUA DE DICHO AGENTE EN LA BOCA Y EN LA TRAYECTORIA GASTROINTESTINAL DESDE UN LUGAR BUCAL O SUBLINGUAL. SE PRESENTAN TAMBIEN TABLETAS BUCALES HECHAS DE AZUCARES NO CARIGENICOS Y UN DISPOSITIVO PARA SUJETAR UNA TABLETA O PASTILLA EN UN LUGAR DENTRO DE LA BOCA DEL PACIENTE, DESDE EL QUE UN INGREDIENTE ACTIVO, DE LA TABLETA O PASTILLA, ES LIBERADO POR LA ACCION DE LA SALIVA DEL PACIENTE.
ES90913280T 1989-08-25 1990-08-24 Composiciones farmaceuticas y un dispositivo para administrar las mismas. Expired - Lifetime ES2079485T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898919446A GB8919446D0 (en) 1989-08-25 1989-08-25 Pharmaceutical compositions
GB898919447A GB8919447D0 (en) 1989-08-25 1989-08-25 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2079485T3 true ES2079485T3 (es) 1996-01-16

Family

ID=26295819

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90913280T Expired - Lifetime ES2079485T3 (es) 1989-08-25 1990-08-24 Composiciones farmaceuticas y un dispositivo para administrar las mismas.

Country Status (13)

Country Link
US (1) US5437872A (es)
EP (1) EP0489096B1 (es)
JP (1) JP2918331B2 (es)
KR (1) KR0173135B1 (es)
AT (1) ATE130189T1 (es)
AU (2) AU652723B2 (es)
CA (1) CA2064882A1 (es)
DE (1) DE69023654T2 (es)
ES (1) ES2079485T3 (es)
HK (1) HK116896A (es)
IE (1) IE69578B1 (es)
NZ (1) NZ235063A (es)
WO (1) WO1991002518A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US5549911A (en) * 1994-01-14 1996-08-27 Laboratoires Des Produits Ethiques Ethypharm Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
EP0748588B1 (en) * 1995-05-12 2000-10-11 Dsm N.V. Fungicide compositions
GB2319726A (en) * 1996-11-12 1998-06-03 Procter & Gamble Polymyxin A, B, C, D or E containing compositions for the treatment of periodontal disease, plaque and breath malodor
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6358060B2 (en) * 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6911455B2 (en) * 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
AU2001261744A1 (en) * 2000-05-19 2001-12-03 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US7878801B2 (en) * 2000-09-21 2011-02-01 Align Technology, Inc. Systems and methods for dental appliance compliance indication
US6607382B1 (en) * 2000-09-21 2003-08-19 Align Technology, Inc. Methods and systems for concurrent tooth repositioning and substance delivery
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
JP4019374B2 (ja) * 2001-07-27 2007-12-12 アステラス製薬株式会社 口腔内速崩壊錠用徐放性微粒子含有組成物およびその製造法
WO2004108114A2 (en) * 2003-03-31 2004-12-16 Dinesh Shantilal Patel Anti-fungal composition and a process for its manufacture
US7943585B2 (en) * 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US6997706B2 (en) * 2004-03-04 2006-02-14 Ultradent Products, Inc. Fluoride-releasing pellet kit
US7097449B2 (en) * 2004-03-04 2006-08-29 Ultradent Products, Inc. Dental brackets for retaining a medicament-releasing pellet on a tooth and kits including such brackets
US8899976B2 (en) 2004-09-24 2014-12-02 Align Technology, Inc. Release agent receptacle
US20060115785A1 (en) 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
ES2639565T3 (es) 2005-05-03 2017-10-27 The University Of Western Ontario Dispositivo oral y kit para su uso en asociación con el mismo
WO2007095524A2 (en) * 2006-02-13 2007-08-23 Sonoma Holdings Llc Passive time released solute treatment
US8642016B2 (en) * 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US20080031872A1 (en) * 2006-08-02 2008-02-07 Karp Nelson M HIV immunogenic composition and method of administration
US10004657B2 (en) 2008-02-08 2018-06-26 The University Of Western Ontario Method of brain activation
EP2271300A4 (en) 2008-04-15 2017-12-13 Trudell Medical International Swallowing air pulse therapy mouthpiece and method for the use thereof
US8172569B2 (en) 2008-06-12 2012-05-08 Align Technology, Inc. Dental appliance
US8517729B2 (en) 2010-03-04 2013-08-27 The University of Western Ontario and Trudell Medical International Oral mouthpiece and method for the use thereof
US9155317B2 (en) 2011-02-09 2015-10-13 Dsm Ip Assets B.V. Antifungal compositions
EP2967956A4 (en) 2013-03-15 2017-03-22 Trudell Medical International Oral mouthpiece and method for the use thereof
USD773598S1 (en) * 2015-03-13 2016-12-06 The Allen Company, Inc. Target rod holder
JP7125791B2 (ja) * 2018-05-23 2022-08-25 シャンハイ ダブリュディー ファーマシューティカル カンパニー，リミティド 活性薬物成分の放出制御システムおよびその製造方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
WO2019246384A1 (en) 2018-06-21 2019-12-26 Aquestive Therapeutics, Inc. System and method for making personalized individual unit doses containing pharmaceutical actives
CN110859815A (zh) * 2019-12-05 2020-03-06 远大医药（中国）有限公司 一种甲硝唑制剂及制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43437B (en) * 1976-05-05 1989-08-31 Lowey Hans Process for obtaining tablets containing an active component with long lasting effect
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
GB2122892B (en) * 1982-07-02 1986-01-29 Squibb & Sons Inc Nystantin pastille formulation
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4863737A (en) * 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
FR2624739A1 (fr) * 1987-12-17 1989-06-23 Medipro Medicament comprenant l'association de colistine, de neomycine et d'amphotericine b administre par vaporisation

Also Published As

Publication number Publication date
WO1991002518A1 (en) 1991-03-07
CA2064882A1 (en) 1991-02-26
US5437872A (en) 1995-08-01
AU6345290A (en) 1991-04-03
IE903113A1 (en) 1991-02-27
EP0489096A1 (en) 1992-06-10
IE69578B1 (en) 1996-10-02
AU5274093A (en) 1994-02-24
KR0173135B1 (en) 1999-02-01
DE69023654T2 (de) 1996-04-18
JP2918331B2 (ja) 1999-07-12
EP0489096B1 (en) 1995-11-15
AU652723B2 (en) 1994-09-08
NZ235063A (en) 1994-11-25
JPH05503289A (ja) 1993-06-03
DE69023654D1 (de) 1995-12-21
HK116896A (en) 1996-07-12
KR920703018A (ko) 1992-12-17
ATE130189T1 (de) 1995-12-15

Similar Documents

Publication Publication Date Title
ES2079485T3 (es) Composiciones farmaceuticas y un dispositivo para administrar las mismas.
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
MY100721A (en) Therapeutic agent.
ATE427103T1 (de) Orale verabreichung von adenosin analogen
CA2029046A1 (en) Sustained release compositions for treating periodontal disease
DE69622980D1 (de) Bioadhäsives Arzneimittel zur kontrollierten Freisetzung von Wirkstoffen
DE69432076T2 (de) Neue pharmazeutische formulierungen
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
IL117356A0 (en) Controlled release pharmaceutical composition for oral administration
ES2053702T3 (es) Nuevas formulas de galenica de accion programada.
DK0389224T3 (da) Intraoralt medikamentfrigivelsessystem
DE60020501D1 (de) Trimetazidinhaltige Matrixtablette zur verlängerten Wirkstofffreisetzung nach oraler Gabe
HRP20010684B1 (en) Directly compressible matrix for controlled release of single daily doses of clarithromycin
NO963634D0 (no) Antihostepreparat inneholdende et antihostemiddel og benzydamin
Meredith et al. The epidemiology of acute acetaminophen poisoning in England and Wales
AR030551A1 (es) Uso de nefiracetam para la fabricacion de un medicamento para eltratamiento de la neurodegeneracion y composicion farmaceutica resultante
BR0313175A (pt) Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
Matthews Drug-induced esophagitis
ES2043567T1 (es) Una composicion farmaceutica de liberacion controlada para uso oral que contiene farmacos anti-inflamatorios no esteroideos.
BE880648A (fr) Nouvelles formes galeniques d'administration de medicaments par voie orale, aliberation programmee et leurs procedes de preparation
ATE15139T1 (de) Phosphonomycine pharmazeutische zusammensetzung in tablettenform.
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive method
DK493887A (da) Buccal formulering
ES2135424T3 (es) Composicion oral a base de ibuprofeno.
TH22304A (th) สารเตรียมทางเภสัชกรรมแบบหลายหน่วยที่มีสารยัยยั้งปั๊มโปรตอน

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 489096

Country of ref document: ES